8.25
price down icon1.79%   -0.15
after-market アフターアワーズ: 8.73 0.48 +5.82%
loading
前日終値:
$8.40
開ける:
$8.28
24時間の取引高:
315.02K
Relative Volume:
3.41
時価総額:
$262.73M
収益:
$193.67M
当期純損益:
$4.82M
株価収益率:
17.93
EPS:
0.46
ネットキャッシュフロー:
$15.53M
1週間 パフォーマンス:
+1.35%
1か月 パフォーマンス:
+4.96%
6か月 パフォーマンス:
-10.13%
1年 パフォーマンス:
-21.13%
1日の値動き範囲:
Value
$8.21
$8.72
1週間の範囲:
Value
$8.13
$8.72
52週間の値動き範囲:
Value
$7.15
$13.77

Zynex Inc Stock (ZYXI) Company Profile

Name
名前
Zynex Inc
Name
セクター
Healthcare (1176)
Name
電話
(800)-495-6670
Name
住所
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
職員
1,101
Name
Twitter
@zynexmedical
Name
次回の収益日
2024-10-24
Name
最新のSEC提出書
Name
ZYXI's Discussions on Twitter

ZYXI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
9.30 0 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.72 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1402 295.87M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.6475 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.32 142.97M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
4.01 52.16M 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-10-16 開始されました RBC Capital Mkts Outperform
2023-01-06 アップグレード Piper Sandler Neutral → Overweight
2022-02-28 繰り返されました B. Riley Securities Buy
2021-07-16 アップグレード B. Riley Securities Neutral → Buy
2021-03-09 アップグレード Northland Capital Market Perform → Outperform
2021-02-26 ダウングレード B. Riley Securities Buy → Neutral
2021-01-29 ダウングレード Piper Sandler Overweight → Neutral
2021-01-28 ダウングレード Northland Capital Outperform → Market Perform
2020-09-14 アップグレード H.C. Wainwright Neutral → Buy
2020-09-09 アップグレード Northland Capital Market Perform → Outperform
2020-07-29 アップグレード B. Riley FBR Neutral → Buy
2020-07-20 開始されました Piper Sandler Overweight
2020-07-13 ダウングレード B. Riley FBR Buy → Neutral
2020-07-10 繰り返されました H.C. Wainwright Neutral
2020-06-16 ダウングレード Northland Capital Outperform → Market Perform
2020-05-19 ダウングレード H.C. Wainwright Buy → Neutral
2020-04-01 開始されました Northland Capital Outperform
2019-09-23 開始されました H.C. Wainwright Buy
すべてを表示

Zynex Inc (ZYXI) 最新ニュース

pulisher
Dec 19, 2024

Electrotherapy System Market Future Business Opportunities - openPR

Dec 19, 2024
pulisher
Dec 18, 2024

How to Take Advantage of moves in (ZYXI) - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 18, 2024

Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada

Dec 18, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to expand pain management access - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire) - Aktiellt

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news

Dec 17, 2024
pulisher
Dec 16, 2024

Zynex, Inc. Sets Second Quarter 2023 Earnings Call - GuruFocus.com

Dec 16, 2024
pulisher
Dec 13, 2024

Zynex Announces Completion of Its Laser Pulse Oximetry Trial - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 13, 2024

Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI - Proactive financial news

Dec 13, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - The Malaysian Reserve

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex to Present at the HC Wainwright Global Investment Conference - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits i - GuruFocus.com

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex study highlights precision of laser-based pulse oximeter in reducing racial bias - Proactive Investors USA

Dec 12, 2024
pulisher
Dec 12, 2024

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters – Company AnnouncementFT.com - Financial Times

Dec 12, 2024
pulisher
Dec 11, 2024

Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN

Dec 11, 2024
pulisher
Dec 10, 2024

Zynex Sets Third Quarter 2024 Earnings Call - Longview News-Journal

Dec 10, 2024
pulisher
Dec 09, 2024

Zynex Inc. Achieves $200M Milestone and Sets Ambitious Goals for 2025 - Proactive Investors UK

Dec 09, 2024
pulisher
Dec 09, 2024

Non Invasive Pain Management Devices Market Overall Study - openPR

Dec 09, 2024
pulisher
Dec 07, 2024

Objective long/short (ZYXI) Report - Stock Traders Daily

Dec 07, 2024
pulisher
Dec 07, 2024

Zynex's (ZYXI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

CHIEF FINANCIAL OFFICER Moorhead Daniel J was granted 5,000 shares and covered exercise/tax liability with 4,879 shares, decreasing direct ownership by 42% to 35,561 units (SEC Form 4) - Quantisnow

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex stock retains buy rating on FDA progress - Investing.com

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex stock retains buy rating on FDA progress By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex completes clinical verification trial of pulse oximeter - Yahoo Finance

Dec 06, 2024
pulisher
Dec 06, 2024

Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, NeuroMetrix - openPR

Dec 06, 2024
pulisher
Dec 06, 2024

Hotchkis & Wiley Capital Management LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex completes trial for new pulse oximeter technology By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 05, 2024

Laser-Based Pulse Oximeter Advances Toward FDA Submission - Sleep Review

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex eyes FDA submission for NiCO pulse oximeter following successful verification trial - Proactive Investors Australia

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex completes trial for new pulse oximeter technology - Investing.com

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex Completes Breakthrough Clinical Trial for Next-Gen Laser Pulse Oximeter at Duke University - StockTitan

Dec 05, 2024
pulisher
Dec 04, 2024

Zynex Announces Open Oximetry Project Membership - GuruFocus.com

Dec 04, 2024
pulisher
Dec 03, 2024

Zynex CFO Daniel Moorhead sells $80,800 in company stock By Investing.com - Investing.com Nigeria

Dec 03, 2024
pulisher
Dec 03, 2024

Insider Sell Alert: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com

Dec 03, 2024
pulisher
Dec 03, 2024

Zynex CFO Daniel Moorhead sells $80,800 in company stock - Investing.com

Dec 03, 2024
pulisher
Dec 03, 2024

Zynex joins Open Oximetry Project as it advances innovative NiCO pulse oximeter - Proactive Investors Australia

Dec 03, 2024

Zynex Inc (ZYXI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Zynex Inc (ZYXI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 14 '24
Sale
8.09
2,000
16,180
14,603,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 12 '24
Sale
9.24
2,000
18,480
14,607,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 07 '24
Sale
9.17
2,000
18,340
14,613,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 11 '24
Sale
9.09
2,000
18,180
14,609,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 08 '24
Sale
8.77
2,000
17,540
14,611,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 13 '24
Sale
8.37
2,000
16,740
14,605,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 06 '24
Sale
8.82
2,000
17,640
14,615,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 04 '24
Sale
8.67
2,000
17,340
14,619,350
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 05 '24
Sale
8.05
2,000
16,100
14,617,662
MOORHEAD DANIEL J
CHIEF FINANCIAL OFFICER
Nov 01 '24
Sale
8.59
10,000
85,900
44,878
$2.19
price down icon 0.23%
medical_distribution YI
$0.88
price up icon 16.96%
medical_distribution AHG
$1.23
price up icon 3.36%
medical_distribution OMI
$12.52
price down icon 0.79%
$30.86
price down icon 0.16%
大文字化:     |  ボリューム (24 時間):